Private Investment firm Czura Thornton today introduces Clearstone Central Laboratories

02.11.2009


 

 

NEW BRUNSWICK, N.J., Nov. 2 /PRNewswire/ -- In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to announce the acquisition of Clearstone Central Laboratories by Czura Thornton on behalf of a group of private investors. Clearstone intends to maintain the integrity of its operational teams and continue to invest in strengthening the company's focus on exceptional client service. Combined with the Company's renewed focus on the consistent delivery of high quality service, flexibility and responsiveness that private ownership allows, Clearstone looks forward to expanding its market reach." 

Clearstone Central Laboratories, formerly MDS Pharma Services' Central Labs business, is among the largest private Global Central Laboratory companies solely focused on clinical research and cardiac services. Through a unique network of wholly owned CAP certified laboratories, Clearstone offers central laboratory services spanning the clinical development lifecycle. With strategically placed laboratories in the Americas, Europe and Asia, all are equivalently equipped and harmonized to provide consistent, dependable results across programs, study phases and geographies. 


In addition, Clearstone leverages information technology tools aligned with value add project management principles for managing global clinical trials. Each of its laboratories utilizes the company's centralized APOLLO-CLPM™ (Central Laboratory Protocol Manager) enabling Clearstone project management teams with real-time visibility to component and test level data. Viq Pervaaz, Vice President of Global Project Management commented, "We facilitate our strong project management and data management teams with innovative technology solutions and an advanced web based protocol management system to meet the needs of our clients."  

About Czura Thornton: Czura Thornton is a private investment group that was founded by Tony Czura and Nick Thornton in 2003. The group, which owns leading CRO Chiltern (www.chiltern.com), on behalf of the Galaxy Limited Partnership has arranged investments in the life sciences, international trade, property and automotive sectors. In particular Messrs Czura and Thornton have extensive international experience in the laboratory and CRO sectors. For further information see www.czurathornton.com.

About Clearstone Central Laboratories: Clearstone Central Laboratories is a leading global Central Lab provider offering clinical laboratory and cardiac services solutions. Spanning the globe with 600 people and facilities in Paris, Hamburg, Toronto, New Jersey, *Beijing and Singapore.  For further information see www.clearstonelabs.com
*The acquisition of the China business is pending subject to receipt of required Chinese governmental approvals.

CONTACT:
Elan Josielewski,
Clearstone Central Laboratories,
+1-732-951-3250,
Elan.Josielewski@clearstonelabs.com
 

Back to list

Contact us

Geneva

Chemin de la Moёtte 12
Landecy, Geneva 1257
Switzerland
Telephone +41 22 758 4045
Facsimile +44 845 280 8170

Saint Petersburg

Moika River Embankment, 27,
St.Petersburg, 191186,
Russia
Tel: +7 812 493 2340
Fax: +7 812 493 2341

EMail:
Links: http://czurathornton.com/links